Iress Ltd (IRE)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 5.720 |
|---|---|
| 52-week range | 5.040 – 10.380 |
| Return, 1 month / 3 months | +5.5% / −10.0% |
| Return, 1 year / 3 years | −33.5% / +13.1% |
| Trend | Below its 200-day average |
| RSI (14) | 58 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -44.8% |
| Average daily value traded | 7.40M AUD |
| Dividend yield | 4.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Iress Ltd is a software company that supplies technology to the financial services industry. It builds and supports platforms used by financial advisers, mortgage brokers, trading firms and wealth managers, covering areas such as advice, trading, mortgages and data. Its customers are mainly financial institutions, professional services firms and intermediaries. The company is based in Melbourne, Australia, and serves clients in several countries.
The shares are listed on the Australian Securities Exchange in Australia under the code IRE, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Iress Ltd (IRE) trades on the Australian Securities Exchange in Australia. It last closed at AUD 5.720 on 23 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 698 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 33.5% and over the last three months it fell 10.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -11.1% | ||
| From 52-week high | -40.9% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.0% | ||
| 6-month return | -17.3% | ||
| 12-month return, skipping the last month | -37.0% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.8% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 7.40M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.7% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.4% |
|---|---|
| 1 month | +5.5% |
| 3 months | −10.0% |
| 6 months | −17.3% |
| 1 year | −33.5% |
| 3 years | +13.1% |
| 5 years | −47.1% |
Signals
| 50-day / 200-day average | 5.638 / 6.436 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.160 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | AUD 0.1400 |
| 10 Mar 2026 | AUD 0.1300 |
| 22 Aug 2025 | AUD 0.0550 |
| 10 Mar 2025 | AUD 0.0750 |
| 23 Feb 2023 | AUD 0.3000 |
| 31 Aug 2022 | AUD 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.